Kuniaki Seyama , Tadashi Sato , Susumu Sato , Toyohiro Hirai , The Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labour and Welfare of Japan
{"title":"Allelic frequency of pathogenic α1-antitrypsin variants in the Japanese population: Results from a survey of open Japanese genetic variation databases","authors":"Kuniaki Seyama , Tadashi Sato , Susumu Sato , Toyohiro Hirai , The Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, Ministry of Health, Labour and Welfare of Japan","doi":"10.1016/j.resinv.2024.07.001","DOIUrl":null,"url":null,"abstract":"<div><p>α<sub>1</sub>-antitrypsin deficiency (AATD) is a hereditary disorder with a global prevalence that differs across regions. AATD is highly prevalent in Europe and North America but rarely found in Asian countries, including Japan, possibly because of the founder effect of the pathogenic <em>SERPINA1</em> variants PI*Z and PI*S. However, AATD remains underdiagnosed even in high-prevalence and low-prevalence regions, possibly because of lack of awareness. In this study, we surveyed open Japanese genetic variation databases to estimate AATD prevalence in Japan. We identified allelic frequencies (AFs) of 5 among the 14 major pathogenic <em>SERPINA1</em> variants from three datasets, collectively derived from 63,119 Japanese participants. The mean AF was determined to be 8.56 × 10<sup>−4</sup> (95% confidence interval [CI]: 6.43 × 10<sup>−4</sup> to 1.12 × 10<sup>−3</sup>). Given that this represents the entire Japanese population, one AATD patient was speculated to be born per 1.37 × 10<sup>6</sup> births (95% CI: 7.97 × 10<sup>5</sup> to 2.42 × 10<sup>6</sup>) in Japan. Our results support the prevailing notion that AATD is extremely rare in Japan.</p></div>","PeriodicalId":20934,"journal":{"name":"Respiratory investigation","volume":"62 5","pages":"Pages 794-797"},"PeriodicalIF":2.4000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory investigation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212534524001023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
α1-antitrypsin deficiency (AATD) is a hereditary disorder with a global prevalence that differs across regions. AATD is highly prevalent in Europe and North America but rarely found in Asian countries, including Japan, possibly because of the founder effect of the pathogenic SERPINA1 variants PI*Z and PI*S. However, AATD remains underdiagnosed even in high-prevalence and low-prevalence regions, possibly because of lack of awareness. In this study, we surveyed open Japanese genetic variation databases to estimate AATD prevalence in Japan. We identified allelic frequencies (AFs) of 5 among the 14 major pathogenic SERPINA1 variants from three datasets, collectively derived from 63,119 Japanese participants. The mean AF was determined to be 8.56 × 10−4 (95% confidence interval [CI]: 6.43 × 10−4 to 1.12 × 10−3). Given that this represents the entire Japanese population, one AATD patient was speculated to be born per 1.37 × 106 births (95% CI: 7.97 × 105 to 2.42 × 106) in Japan. Our results support the prevailing notion that AATD is extremely rare in Japan.